Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Launched by UNIVERSITY OF TENNESSEE · Apr 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Med AAAction Study is researching a new way to help patients with multiple chronic health conditions, such as diabetes, high blood pressure, and heart disease, stick to their medication plans after leaving the hospital. Many people in this group often struggle to take their medications regularly, which can lead to serious health issues and hospital readmissions. This study will compare a special pharmacy-led program, which provides medications without any out-of-pocket costs and offers support to help patients access their medicines, to the usual care they receive after discharge.
To take part in this study, you must be 21 years or older, on Medicaid or uninsured, and have at least two chronic health conditions or take two chronic medications for those conditions. If you join, expect to receive help from certified pharmacy technicians who will assist you in getting your medications and coordinating follow-up care. Over the course of a year, the study will look at how well this program works in improving medication use and reducing hospital visits. This research aims to find better solutions for patients who may face financial, transportation, or other barriers to accessing their medications, ultimately leading to healthier outcomes for them.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Medicaid or uninsured inpatients
- • 21 years or older
- • ≥2 of the complex chronic conditions during index admission or prescribed/using ≥2 chronic medications for these conditions
- • Patients receiving chronic disease medications from the hospital pharmacy.
- • Patients will be eligible if they have multiple complex chronic conditions including diabetes, hypertension, high cholesterol, coronary artery disease, congestive heart failure, chronic lung disease, chronic kidney disease, arrhythmia, stroke, psychiatric disorders including depression and anxiety, or who are prescribed or using anticoagulants.
- Exclusion Criteria:
- • Medicare and Medicaid dual eligible patients.
- • If the primary reason for the index admission is related to cancer, pregnancy, or a surgical procedure for an acute problem
- • If patients have diagnoses of active psychosis, substance abuse, or suicidal ideation during the index admission.
- • If the planned discharge location is not home.
- • If patients are part of an existing pharmacy discharge program.
About University Of Tennessee
The University of Tennessee is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to improving patient outcomes and fostering scientific discovery, the university engages in a diverse range of studies that encompass various medical disciplines. Leveraging its extensive resources, expert faculty, and state-of-the-art facilities, the University of Tennessee collaborates with healthcare professionals and industry partners to translate research findings into practical applications. Through rigorous ethical standards and a patient-centered approach, the university aims to contribute significantly to the field of medicine and enhance the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Knoxville, Tennessee, United States
Memphis, Tennessee, United States
Patients applied
Trial Officials
Satya Surbhi, PhD
Principal Investigator
UTHSC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported